Dr Srinath Sundararaman, MD | |
500 N Hiatus Rd Ste 200, Pembroke Pines, FL 33026-5213 | |
(954) 437-4800 | |
Not Available |
Full Name | Dr Srinath Sundararaman |
---|---|
Gender | Male |
Speciality | Radiation Oncology |
Experience | 27 Years |
Location | 500 N Hiatus Rd Ste 200, Pembroke Pines, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336142488 | NPI | - | NPPES |
46650 | Other | FL | BLUE CROSS BLUE SHIELD |
255871800 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0001X | Radiology - Radiation Oncology | ME 77429 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Margaret R Pardee Memorial Hospital | Hendersonville, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Henderson County Hospital Corporation | 8123938115 | 177 |
News Archive
Male football players are at a greater risk of injury five minutes after a card has been given or after a goal has been scored. The frequency of player injuries also increases when their own team is in the lead.
In the Center for Global Development's (CGD) "Global Prosperity Wonkcast," Lawrence MacDonald this week interviews Amanda Glassman, a CGD research fellow and director of the center's global health policy program.
Ireland's Minister for Business, Enterprise, and Innovation, Heather Humphreys, TD, has today announced that a special Science Foundation Ireland Future Innovator Prize of €500,000 has been granted to University College Dublin researcher, Professor Dominic Zerulla.
Stand Up To Cancer, the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that Jeffrey A. Sosman, M.D., a Stand Up To Cancer Melanoma Dream Team investigator, William Pao, M.D., Ph.D., a 2009 Stand Up To Cancer Innovative Research Grant recipient and colleagues identified two novel BRAF fusions in melanomas previously considered to be negative for molecular targets, and that melanomas with these fusions were found to be potentially sensitive to anticancer drugs called MEK inhibitors, according to a study recently published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
A subgroup of patients with osteosarcoma - a form of bone cancer - could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators at University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.
› Verified 2 days ago
Entity Name | Henderson County Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447444559 PECOS PAC ID: 8123938115 Enrollment ID: O20040611001396 |
News Archive
Male football players are at a greater risk of injury five minutes after a card has been given or after a goal has been scored. The frequency of player injuries also increases when their own team is in the lead.
In the Center for Global Development's (CGD) "Global Prosperity Wonkcast," Lawrence MacDonald this week interviews Amanda Glassman, a CGD research fellow and director of the center's global health policy program.
Ireland's Minister for Business, Enterprise, and Innovation, Heather Humphreys, TD, has today announced that a special Science Foundation Ireland Future Innovator Prize of €500,000 has been granted to University College Dublin researcher, Professor Dominic Zerulla.
Stand Up To Cancer, the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that Jeffrey A. Sosman, M.D., a Stand Up To Cancer Melanoma Dream Team investigator, William Pao, M.D., Ph.D., a 2009 Stand Up To Cancer Innovative Research Grant recipient and colleagues identified two novel BRAF fusions in melanomas previously considered to be negative for molecular targets, and that melanomas with these fusions were found to be potentially sensitive to anticancer drugs called MEK inhibitors, according to a study recently published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
A subgroup of patients with osteosarcoma - a form of bone cancer - could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators at University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.
› Verified 2 days ago
Entity Name | Outer Banks Professional Services, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891050357 PECOS PAC ID: 3173652096 Enrollment ID: O20100602000156 |
News Archive
Male football players are at a greater risk of injury five minutes after a card has been given or after a goal has been scored. The frequency of player injuries also increases when their own team is in the lead.
In the Center for Global Development's (CGD) "Global Prosperity Wonkcast," Lawrence MacDonald this week interviews Amanda Glassman, a CGD research fellow and director of the center's global health policy program.
Ireland's Minister for Business, Enterprise, and Innovation, Heather Humphreys, TD, has today announced that a special Science Foundation Ireland Future Innovator Prize of €500,000 has been granted to University College Dublin researcher, Professor Dominic Zerulla.
Stand Up To Cancer, the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that Jeffrey A. Sosman, M.D., a Stand Up To Cancer Melanoma Dream Team investigator, William Pao, M.D., Ph.D., a 2009 Stand Up To Cancer Innovative Research Grant recipient and colleagues identified two novel BRAF fusions in melanomas previously considered to be negative for molecular targets, and that melanomas with these fusions were found to be potentially sensitive to anticancer drugs called MEK inhibitors, according to a study recently published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
A subgroup of patients with osteosarcoma - a form of bone cancer - could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators at University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.
› Verified 2 days ago
Entity Name | Nhcs Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215336870 PECOS PAC ID: 7719209154 Enrollment ID: O20141215000093 |
News Archive
Male football players are at a greater risk of injury five minutes after a card has been given or after a goal has been scored. The frequency of player injuries also increases when their own team is in the lead.
In the Center for Global Development's (CGD) "Global Prosperity Wonkcast," Lawrence MacDonald this week interviews Amanda Glassman, a CGD research fellow and director of the center's global health policy program.
Ireland's Minister for Business, Enterprise, and Innovation, Heather Humphreys, TD, has today announced that a special Science Foundation Ireland Future Innovator Prize of €500,000 has been granted to University College Dublin researcher, Professor Dominic Zerulla.
Stand Up To Cancer, the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that Jeffrey A. Sosman, M.D., a Stand Up To Cancer Melanoma Dream Team investigator, William Pao, M.D., Ph.D., a 2009 Stand Up To Cancer Innovative Research Grant recipient and colleagues identified two novel BRAF fusions in melanomas previously considered to be negative for molecular targets, and that melanomas with these fusions were found to be potentially sensitive to anticancer drugs called MEK inhibitors, according to a study recently published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
A subgroup of patients with osteosarcoma - a form of bone cancer - could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators at University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Srinath Sundararaman, MD 500 N Hiatus Rd Ste 200, Pembroke Pines, FL 33026-5213 Ph: (954) 437-4800 | Dr Srinath Sundararaman, MD 500 N Hiatus Rd Ste 200, Pembroke Pines, FL 33026-5213 Ph: (954) 437-4800 |
News Archive
Male football players are at a greater risk of injury five minutes after a card has been given or after a goal has been scored. The frequency of player injuries also increases when their own team is in the lead.
In the Center for Global Development's (CGD) "Global Prosperity Wonkcast," Lawrence MacDonald this week interviews Amanda Glassman, a CGD research fellow and director of the center's global health policy program.
Ireland's Minister for Business, Enterprise, and Innovation, Heather Humphreys, TD, has today announced that a special Science Foundation Ireland Future Innovator Prize of €500,000 has been granted to University College Dublin researcher, Professor Dominic Zerulla.
Stand Up To Cancer, the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that Jeffrey A. Sosman, M.D., a Stand Up To Cancer Melanoma Dream Team investigator, William Pao, M.D., Ph.D., a 2009 Stand Up To Cancer Innovative Research Grant recipient and colleagues identified two novel BRAF fusions in melanomas previously considered to be negative for molecular targets, and that melanomas with these fusions were found to be potentially sensitive to anticancer drugs called MEK inhibitors, according to a study recently published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
A subgroup of patients with osteosarcoma - a form of bone cancer - could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators at University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.
› Verified 2 days ago
Geetika Arora Klevos, M.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 15735 Pines Blvd, Pembroke Pines, FL 33027 Phone: 954-517-1725 Fax: 954-517-1729 | |
Kyungmin Kang, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 N Hiatus Rd Ste 200, Pembroke Pines, FL 33026 Phone: 954-437-4800 Fax: 954-437-6628 | |
Dr. Howard T. Heller, MD Radiology Medicare: Medicare Enrolled Practice Location: 9050 Pines Blvd Ste 200, Pembroke Pines, FL 33024 Phone: 954-437-4800 Fax: 954-437-6628 | |
Elitsa Ivanova, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Memorial Hospital West, 703 North Flamingo Road, Pembroke Pines, FL 33028 Phone: 954-844-7315 | |
Matthew L Hoffman, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Memorial Regional Pembroke, 7800 Sheridan Street, Pembroke Pines, FL 33024 Phone: 954-967-2051 | |
Dr. Hugh M Eisen, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 15811 Sw 14th St, Pembroke Pines, FL 33027 Phone: 954-435-1730 |